Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation.
Alberto BenazzoAra ChoAnna NechayStefan SchwarzFlorian FrommletThomas WekerleKonrad HoetzeneckerPeter JakschPublished in: Trials (2021)
EUDRACT Nr 2018-001680-24. Registered on 15 May 2018.